Prescription Medicines
Vitapran inj.
- Product Category
- Active Vitamin Injection
- Active Ingredients
- Fursultiamine hydrochloride
- Appearance
- Brown ampoule containing a colorless or light yellow clear liquid
01 / 02
1. Composition and Strength
in 1 mL
- Active ingredient: Fursultiamine hydrochloride (KP) 5.46mg (5mg as fursultiamine)
- Additives: water for injection, glucose
2. Effectiveness
• Prevention and treatment of vitamin B1 deficiency
• As the demand for vitamin B1 increases, it is supplied when intake from food is insufficient (wasting disease, hyperthyroidism, pregnant women, lactating women, during strenuous physical labor, etc.)
• Werinche encephalopathy disease
• BeriberiHeart Disorders
• Cases presumed to be involved in vitamin B1 deficiency or metabolic disorders due to the following diseases:
1) Neuralgia
2) Muscle pain, joint pain
3) Peripheral neuritis, peripheral nerve paralysis
4) Myocardial metabolic disorders
5) Postoperative intestinal paralysis
In cases where vitamin B1 deficiency or metabolic disorders are presumed to be involved, it is ineffective and should not be used without purpose for about 1 month.
3. Dosage and dosage
As fursultiamine, adults usually inject 5 to 100 mg per day subcutaneously, intramuscularly, or intravenously.
Increase or decrease appropriately depending on symptoms.
4. Precautions for use
1. Warning
Ampoule injections may be mixed with glass fragments when cutting the container, which may cause adverse reactions. Therefore, cut them carefully to minimize the mixing of glass fragments when using them, and be especially careful when using them in children and the elderly (limited to glass ampoule injections).
2. Do not administer to the following patients.
Patients with a history of hypersensitivity to this drug or its components
3. Administer with caution to the following patients.
Patients with a history of drug hypersensitivity reaction
4. Adverse reactions
1) Serious adverse reactions
In rare cases, shock may occur, so observe thoroughly, and if symptoms such as decreased blood pressure, chest pain, or difficulty in breathing appear, immediately stop administration and take appropriate measures.
2) Other adverse reactions
(1) Hypersensitivity reaction: In rare cases, hypersensitivity reactions such as rash may occur, so if symptoms appear, discontinue administration.
(2) Digestive system: rarely nausea, vomiting, glossitis, sometimes diarrhea
(3) Others: Occasional headache, frequent urination
5. Application precautions
1) Since intravenous injection may cause vascular pain, the injection speed should be as slow as possible.
2) As a general precaution when using injection fluid, do not use the remaining amount after partial use to avoid contamination by bacteria, etc.
3) Ampoule cut: This medicine uses a one-point cut ampoule, so place the mark on the head of the ampoule upward and apply light pressure to the opposite side (downward direction) to cut. Additionally, to avoid contamination of foreign matter when cutting the ampoule, clean the area around the top by wiping it with an ethanol cotton, etc. (ampoules only).
6. Storage and handling precautions
1) Keep out of reach of children.
2) Be careful because changing it into another container may cause an accident or is undesirable in terms of maintaining quality.
5. How to save
Light-proof sealed container, stored at room temperature (1~30℃)
6. Packaging unit
5ml x 20 ampoules
7. Expiration date
36 months from date of manufacture
in 1 mL
- Active ingredient: Fursultiamine hydrochloride (KP) 5.46mg (5mg as fursultiamine)
- Additives: water for injection, glucose
2. Effectiveness
• Prevention and treatment of vitamin B1 deficiency
• As the demand for vitamin B1 increases, it is supplied when intake from food is insufficient (wasting disease, hyperthyroidism, pregnant women, lactating women, during strenuous physical labor, etc.)
• Werinche encephalopathy disease
• BeriberiHeart Disorders
• Cases presumed to be involved in vitamin B1 deficiency or metabolic disorders due to the following diseases:
1) Neuralgia
2) Muscle pain, joint pain
3) Peripheral neuritis, peripheral nerve paralysis
4) Myocardial metabolic disorders
5) Postoperative intestinal paralysis
In cases where vitamin B1 deficiency or metabolic disorders are presumed to be involved, it is ineffective and should not be used without purpose for about 1 month.
3. Dosage and dosage
As fursultiamine, adults usually inject 5 to 100 mg per day subcutaneously, intramuscularly, or intravenously.
Increase or decrease appropriately depending on symptoms.
4. Precautions for use
1. Warning
Ampoule injections may be mixed with glass fragments when cutting the container, which may cause adverse reactions. Therefore, cut them carefully to minimize the mixing of glass fragments when using them, and be especially careful when using them in children and the elderly (limited to glass ampoule injections).
2. Do not administer to the following patients.
Patients with a history of hypersensitivity to this drug or its components
3. Administer with caution to the following patients.
Patients with a history of drug hypersensitivity reaction
4. Adverse reactions
1) Serious adverse reactions
In rare cases, shock may occur, so observe thoroughly, and if symptoms such as decreased blood pressure, chest pain, or difficulty in breathing appear, immediately stop administration and take appropriate measures.
2) Other adverse reactions
(1) Hypersensitivity reaction: In rare cases, hypersensitivity reactions such as rash may occur, so if symptoms appear, discontinue administration.
(2) Digestive system: rarely nausea, vomiting, glossitis, sometimes diarrhea
(3) Others: Occasional headache, frequent urination
5. Application precautions
1) Since intravenous injection may cause vascular pain, the injection speed should be as slow as possible.
2) As a general precaution when using injection fluid, do not use the remaining amount after partial use to avoid contamination by bacteria, etc.
3) Ampoule cut: This medicine uses a one-point cut ampoule, so place the mark on the head of the ampoule upward and apply light pressure to the opposite side (downward direction) to cut. Additionally, to avoid contamination of foreign matter when cutting the ampoule, clean the area around the top by wiping it with an ethanol cotton, etc. (ampoules only).
6. Storage and handling precautions
1) Keep out of reach of children.
2) Be careful because changing it into another container may cause an accident or is undesirable in terms of maintaining quality.
5. How to save
Light-proof sealed container, stored at room temperature (1~30℃)
6. Packaging unit
5ml x 20 ampoules
7. Expiration date
36 months from date of manufacture
Product Updates
Total 1items
| No. | Product Name | Details | Date of Change | Download |
|---|---|---|---|---|
| 1 | Vitapran inj. | Vitafran (effectiveness, dosage, precautions for use... | 2013.12.30 | HWP2012 Pharmaceutical Literature Re-evaluation (Vitafran Injection).hwp |